1. Introduction to the Project

1.1 Project background

1.1.1 Product introduction

This project is located in the starting area of Yongchun Modern Biomedical City in Changchun City. Yongchun Modern Biomedical City is a project covering an area of 256 square kilometers, with a core area of 28 square kilometers. The goal of the Biomedical City is to develop ‘new quality productive forces’. In order to achieve this goal, led by scientific and technological innovation, the project pursues economic elasticity and vitality, and lays emphasis on the development of people-oriented vitality. Centering on the core concept of ‘the future of the industry + the industry of the future’, Yongchun Modern Biomedical City is committed to building a ‘1+2+N’ modern industrial system. ‘1’ represents one core industry, ‘2’ represents two supporting industries, and ‘N’ represents multiple related emerging industries, which jointly build a diversified and sustainable industrial ecosystem.

1.1.2 Market prospect

(1) Development status of modern drug warehousing

With the rapid development of science and technology and the increasing demand for medical care, the field of modern drug warehousing has achieved significant progress and improvement. Currently, automation and information technology are playing an increasingly critical role in drug warehousing management. For example, intelligent warehousing system can achieve rapid positioning and efficient management of drugs through the application of bar code or RFID technology, which has not only greatly improved the logistics efficiency but also significantly enhanced the management accuracy. In addition, advanced temperature and humidity control systems have guaranteed the stable quality of drugs during storage, and the application of these technologies is particularly important especially in the fields of biological products and vaccines that require special storage conditions.

Even so, the challenges faced by modern drug warehousing in the development process shall not be underestimated. Firstly, there are numerous types of drugs, and the storage requirements for different drugs vary greatly, which poses significant challenges to warehousing management. Secondly, the safety requirements for drug warehousing are extremely high, and any mistake can lead to serious consequences. Therefore, the warehousing system must have strict safety monitoring and emergency response mechanisms to guarantee safe storage and management of the drugs.

To effectively address these challenges, it is particularly important to introduce new ideas and technologies. For example, block chain technology can be considered to enhance the transparency and traceability of the drug supply chain. Through block chain, the circulation information of each batch of drugs can be recorded in real time and maintained in a tamper-resistant state, thus effectively preventing the circulation of counterfeit and shoddy drugs and guaranteeing the safety of public medication. In addition, using big data analysis to predict the drug demand can optimize inventory management, reduce waste, and improve the warehousing efficiency.

To sum up, modern drug warehousing has made significant progress in technological innovation and management optimization, but meanwhile, it also faces many challenges. By introducing new technologies such as block chain and big data, we can not only improve the safety and efficiency of drug warehousing, but also further enhance the management level of the entire drug supply chain. In the future, with the continuous development and progress of technologies, drug warehousing will become more intelligent and refined, and can better serve the public health, providing strong support for the development of the medical industry.

(2) Prospect analysis of modern drug warehousing integration

With the rapid development of science and technology and the increasing demand for medical care, drug warehousing integration has become an important trend that cannot be ignored in the field of medicine logistics. Firstly, by adopting advanced information technology and automation equipment, the drug warehousing integration can significantly improve the logistics efficiency, reduce human errors, and guarantee the safety of drugs. For example, using Internet of Things (IoT) technology to achieve real-time tracking and monitoring of the drugs can effectively prevent loss and damage of the drugs during transportation and storage, thereby guaranteeing the quality and safety of the drugs.

Secondly, drug warehousing integration can help reduce the operating cost. Through centralized management, it can achieve scale economy, reduce duplicate investment, and optimize the resource allocation. In addition, an integrated warehousing system can provide more flexible inventory management. It can adjust the inventory level in a timely manner according to market demand to avoid surplus or shortage, thus improving the utilization efficiency and economic benefits of the resources.

Once again, drug warehousing integration plays an important role in improving the service quality. The integrated system can provide more accurate delivery services, shorten the time it takes for drugs to reach the patients from the warehouse, and improve the patient satisfaction. Meanwhile, through data analysis, it can better predict the market trend, and provide scientific basis for drug production and supply chain management, thereby optimizing the efficiency of the entire medical supply chain.

To sum up, the modern drug warehousing integration can not only improve the logistics efficiency and reduce costs, but also enhance the service quality and meet the increasing demands for medical care. In the future, with the further development and application of technology, the drug warehousing integration will have a more profound impact on the medicine industry, driving the entire industry towards a more efficient, intelligent, and sustainable direction.

1.1.3 Advantageous conditions of project construction

(1) Policy conditions

In the 14^th Five-year Plan for Bioeconomy Development by the National Development and Reform Commission, it was mentioned that we should focus on drugs, vaccines, advanced diagnostic and treatment technologies and equipment, biomedical materials, precision medicine, inspection and testing, biological health and rehabilitation and other directions to enhance the original innovation capability and strengthen scientific research on drug regulation; With the goal of promoting breakthroughs in key technologies and the transformation and application of scientific and technological achievements, we should support the leading enterprises to take the lead in forming innovation consortia, undertake the construction of innovation platforms such as industrial innovation centers, engineering research centers, technology innovation centers, and manufacturing innovation centers, etc., encourage innovation and entrepreneurship in the field of biotechnology, and support the development of small and medium-sized enterprises.

In the Implementation Plan for Promoting the High-quality Development of Biomedical and High-performance Medical Device Industry in Jilin Province, it was mentioned that we should accelerate the development of medical devices. We should give full play to the research and development advantages of institutions such as the Changchun Institute of Optics, Fine Mechanics and Physics, Changchun Institute of Optics, and Jilin University, etc. in the fields of optoelectronic technology, medical implant materials, and molecular diagnostics, etc., with a focus on the research and development and industrialization of strongly innovative and high-value optoelectronic technology, absorbable implantable medical devices, in vitro diagnostic instrument, and matching reagent products.

(2) Talent advantages

Changchun is a well-known high intelligence intensive area in China, with more than ten key universities such as Jilin University, Northeast Normal University, and Changchun University of Science and Technology. It also has national and provincial (ministerial) scientific research institutions such as the Chinese Academy of Sciences, Changchun Branch, Changchun Institute of Optics, Fine Mechanics and Physics, Changchun Institute of Applied Chemistry, as well as scientific research institutions such as design institutes, computing and testing centers, and several key national open laboratories in Changchun. Changchun City has abundant human resources and price advantages. Higher education institutions and research institutions such as Jilin University, Northeast Normal University, Changchun University of Traditional Chinese Medicine, Changchun Institute of Optics, Fine Mechanics and Physics, and Changchun Institute of Applied Chemistry can provide senior management and technical personnel for the implementation of the project.

(3) Location advantages

Changchun has a well-developed transportation network‌, with multiple modes of transportation including railways, highways, aviation, and water transportation. Changchun is the intersection of multiple railway trunk lines such as Harbin-Dalian Railway, Beijing-Harbin Railway, and Jilin-Hunchun Railway, as well as the starting point or passing point of multiple highways such as Beijing-Harbin Expressway and Harbin-Dalian Expressway. Changchun Longjia International Airport is one of the largest aviation hubs in Northeast China, with nearly 100 domestic and international routes.‌ Changchun City has an important strategic position in the Northeast Asia Economic Circle ‌. As an international metropolis in Northeast Asia, Changchun is an important hub connecting Northeast China and North China, as well as a significant political, economic, and cultural center in Northeast China.

(4) Industrial advantages

At the 2023 China Biotech Innovation Conference, the competitiveness ranking of China's biomedical parks was announced. The biomedical industry in Changchun High-tech Industrial Development Zone increased by 2 places in the comprehensive competitiveness ranking, ranking 14th in China, achieving a leap for three consecutive years.

Changchun New Area is the industrial core area of the first batch of national biological industry bases, the largest vaccine production base in Asia, and the largest gene drug production base in China. As an important growth pole for the development of the medical industry in Jilin Province and Changchun City, Changchun New Area has built a relatively complete medical and health industry chain and industrial ecosystem, and planned and constructed a "Changchun Medicine Valley" covering an area of 23.2 square kilometers with high standards.

“Changchun Medicine Valley” has gathered a group of industry-leading enterprises such as Changchun High-tech, GenSci, BCHT and Dirui Industrial, and 210 biomedical and health-related enterprises, including 26 enterprises above designated size, 79 high-tech enterprises, and 45 professional, precision, special and new enterprises. In 2022, the industrial output value of enterprises above designated size was 23.6 billion yuan, a year-on-year growth of 22.3%, accounting for 30.4% of the industrial output value of the whole district; the total output value accounted for 81.6% of the city's biomedical industry and nearly 33.7% of the province, putting the city at the top among all cities in the province.

1.2 Contents and scale of project construction

The project covers an area of 30,000 square meters, with a total construction area of 45,000 square meters. It mainly includes the construction of office bases, production workshops, modern intelligent medical device warehouses, and drug research and development centers, etc.

1.3 Total investment of the project and capital raising

1.3.1 Total investment of the project

The total investment of the project is 300 million yuan, including the construction investment of 240 million yuan.

1.4 Financial analysis and social evaluation

1.4.1 Main financial indexes

After the project reaches the production capacity, its annual sales income will be 333.33 million yuan, its profit will be 100 million yuan, its investment payback period will be 5 years (after the tax, including the construction period of 2 years), and its investment profit rate will be 33.33%.

Note: “10 thousand yuan” in the table is in RMB

1.4.2 Social evaluation

This project not only injects new vitality into the local economy and promotes employment, but also significantly improves the logistics efficiency by optimizing the drug supply chain. In addition, the project has made important contributions to guaranteeing public health and safety. It has guaranteed timely supply and quality control of drugs, and has received unanimous praise from the government, enterprises, and the public. Through the implementation of this project, the competitiveness of relevant regions in the drug industry has been significantly enhanced, laying a solid foundation for future development.

1.5 Cooperative way

Sole proprietorship, joint venture and cooperation.

1.6 What to be invested by the foreign party

Funds, other ways can be discussed in person.

1.7 Site selection of project

Starting area of Yongchun Modern Biomedical City in Changchun.

1.8 Progress of the project

Project planning phase.

2. Introduction to the Partner

2.1 Basic information of unit

Name: Nanguan District People’s Government, Changchun City

Address: No. 123 Fangfei Road, Nanguan District, Changchun City

2.2 Overview

Nanguan District is located in the central southern part of Changchun City. It starts from Renmin Street in the west to connect with Chaoyang District, and ends at Xinfa Road, Shanghai Road, and Guangfu Road in the north to connect with Kuancheng District. It faces Erdao District across the Yitong River in the east and reaches the boundaries of Xinli Town and Yongchun Township in the south to be adjacent to Jingyue Development Zone and High-tech Development Zone. After 9 times of regional adjustments, the area under its jurisdiction has sharply decreased from 497 square kilometers to 80 square kilometers, making it the smallest urban district in Changchun City. It has jurisdiction over total 13 sub-districts, 1 township (town), 7 administrative villages, 65 communities, 665 grids, and 1 city-level development zone (Changchun Economic Development Zone, South of the City). Its registered population is about 488,000, and its actual resident population is about 657,700.

Compared with other urban districts, it has five characteristics:  

Firstly, it has the longest development history. During the reign of Emperor Daoguang in the Qing Dynasty, the largest village within a radius of several hundred miles has been formed. In 1825, the “Changchun Ting” was relocated here, forming the embryonic form of Changchun City. In history, there is a saying that “there was Nanguan first, and then Changchun”. Since its establishment, Changchun City has always been accompanied by the imprint of Nanguan’s development.  

Secondly, it has the highest urbanization rate. After many years of development and construction, Nanguan District has achieved the transformation from urban-rural structure to urban structure. The area north of the Ring Expressway has basically completed full area expropriation, and the detailed control plan for the area south of the Ring Expressway has been approved by the municipal government. Yongchun Modern Biomedical City has been laid out in the south of the city, with accelerating process of urbanization.

Thirdly, it has the most distinct functional zoning. Nanguan District is both an old and a new urban district. After many years of development, it has gradually formed a development pattern of “north-south linkage” and “old-new integration” with Weixing Road as the boundary. The northern old urban district covers an area of about 26 square kilometers, and is a century-old commercial port in Changchun City, with rich traditional commercial and trade formats; It is also the earliest urban district in Changchun, with many industrial and commercial households, old residential communities, religious sites, and special populations. The southern new urban district covers an area of about 33 square kilometers, and is the planned and constructed new urban center of Changchun City. It is also the core area of the regional financial service center in Northeast Asia, gathering 24 high-end commercial buildings such as the Northeast Asia International Financial Center. Grand Shopping Center and Jucheng Huayi Plaza lead the consumption agglomeration, enabling fast-changing development of the modern service industry.  

Fourthly, it has the largest proportion of service industry. In Nanguan District, the primary industry has basically withdrawn, while the secondary industry is gradually transforming. As of the end of 2023, the ratio of its three industries has been 0/8/92, of which the secondary industry mainly consisted of the construction industry, 6 large heat-supply enterprises, and 1 food processing enterprise (Dingfengzhen). Its service industry has become an industry with absolute advantage, contributing 87% to the district-level finance.  

Fifthly, it has the highest GDP per square kilometer of land. As the central urban district of Changchun City, Nanguan District gradually relies on the headquarters and the agglomeration development of building economy, especially the high-quality development of modern service industry led by finance, to break through the development bottleneck of limited land space and single industrial structure. In 2023, its GDP made a historical breakthrough of 50 billion yuan, and its GDP created per square kilometer of land led the city all the time. In 2023, its GDP per square kilometer of land reached 652 million yuan, which was 311 million yuan higher than the average level of the five urban districts.  

2.3 Contact method

2.3.1 Contact method of cooperator

Contact person: Yu Kefei

Tel: +86-431-85289169

2.3.2 Contact method of the city (prefecture) where the project is located

Contact unit: Changchun Cooperation and Exchange Office

Contact person: Zhang Junjie

Tel: +86-15704317930

Fax: +86-431-82700590

E-mail: xmc82763933@163.com